Abstract
Strengths and Limitations of this Study
• National record-linkage analysis of routinely collected data constitutes a powerful resource to model critical care admission and prognosticate death during critical illness.
• This project brought together sixteen electronic data sources through a new record-linkage model for Scotland and was at the forefront of the development of the National Data Safe Haven in Scotland
• For individuals with AP who are not severely ill, electronically-formatted routinely recorded clinical data is less comprehensive and this may have led to a negative reporting bias for events not sufficiently severe to need critical care admission.
• Although we specifically conducted a data accuracy pilot, comparing electronic records with hand-written notes in four separate study sites, certain variables are likely to be more accurate, for example automatically-retrieved Wardwatcher™ critical care data, than others for example comorbidity and hospital immediate discharge summaries.
Introduction Background/rationale
Acute pancreatitis (AP) is an inflammatory disease of the pancreas with potentially devastating consequences for those who suffer a severe attack. Individual estimates of the incidence of AP range from 10 to 78 per 100 000 per year [1] [2] [3] [4] [5] [6] . AP was found to be the most common reason for hospitalization with a gastrointestinal disorder in the US in 2012 7 . The estimated financial cost for AP-related care in the US in 2004 was $3.7 billion, with AP resulting in 277 000 hospital admissions and 475 000 ambulatory visits 8 . The financial cost of treating AP in the UK has been estimated at £200 million per year 9 .
In approximately 20% of patients with AP, severe complications can develop which may evolve into multiple organ dysfunction syndrome (MODS) requiring critical care (CC) support in high dependency (HDU) or intensive treatment units (ITU) 10 11 . AP-MODS usually occurs rapidly, and features of AP-MODS may be present at the time of presentation to hospital 12 . Between 2008 and 2010, 5% of all available intensive care beds in Scotland were taken up by patients with AP 9 ; in tertiary referral centres ITU bed occupancy may reach 9% 13 . The epidemiological risk factors for developing organ dysfunction amongst individuals with AP are not known at present. This knowledge will be important and useful to identify high-risk patients by enhancing the stratification of disease severity, and to influence treatment decisions, plan healthcare, allocate resources and inform trial design. Therefore, there exists a need to understand and identify risk factors for progression to AP-MODS based on laboratory and clinical information leading up to, and at the time of acute presentation to hospital.
The Farr Institute 14 was conceived with the goal of creating a unified healthcare informatics infrastructure to allow interested parties from government, academia, industry, healthcare providers and other related organisations utilise linked electronic healthcare data on a national scale in a secure, confidential and streamlined way for medical research within the UK. Given the substantial healthcare burden of AP, the need for improved understanding and treatment of AP, and the considerable interest in development of novel therapies for AP by us 15 and others, the aim of this study was to harness the power of the Farr Institute capabilities to elucidate the epidemiology of AP with a focus on defining the risk factors for the development of organ failure in AP.
Objectives
Our specific objectives were to use the Farr Institute infrastructure to:
1. Characterize the epidemiology of AP in Scotland 2. Define the determinants of admission to CC and/or death in AP 3. Describe the morbidity, length of critical care stay, organ support and mortality of patients with AP admitted to CC.
Methods

Study design
We undertook a retrospective observational cohort study of linked healthcare records from sixteen electronic data sources in Scotland.
Project structure and Study management
The collaborative core project team consisted of a project manager (PJ), clinician scientists with expertise in AP (DJM, CS), an epidemiologist and statistician from industry (UG, AL), national healthcare data expertise (CG, ADM, FS), data managers, clinical information governance (HW) and clinical statistics and epidemiology expertise (LC, PTD). A project board (including lay membership) met quarterly to oversee the project. The study protocol and analysis plan were agreed in advance by the project board.
Ethical approval, patient confidentiality and data security
We obtained approvals from: National Services Scotland, Privacy Advisory Committee; National Research Ethics Service; National Research and Development Office; the local Research and Development Office for each Health Board; NHS Board Caldicott Guardians, via the Caldicott Guardians' National Scrutiny Process; Scottish Intensive Care Society Audit Group (SICSAG) Steering Group; and General Practitioners (as Caldicott Guardians). The study adhered to strict information governance and security protocols. All primary data was held within the NHS Scotland Information Services Division (ISD) National Safe Haven with access restricted to two named statisticians from University of Dundee (LC, PTD). Industry partners did not have sight of patientlevel data at any stage.
Setting and data sources
The study cohort consisted of all patients who had a general or acute inpatient or day case record of acute pancreatitis in any coding field, coded as K85 under ICD10 K85 process based on a unique patient identifier (the CHI number). There were no exclusion criteria. A pilot study was performed to assess the coding accuracy of AP in SMR01.
Definitions and categories
Acute pancreatitis (AP) was defined as occurring when any elective or emergency admission was coded as ICD10 K85 in any diagnosis field. To account for inaccuracies of coding, True AP (tAP) was predefined as a subset of AP as: upper abdominal pain with or without nausea or vomiting at presentation in the clinical records and a serum amylase or lipase result greater than 3 times the upper limit of the reference range for that laboratory; or CT evidence of AP alone. We predefined severe AP (sAP) as a subset of tAP as: tAP requiring admission to CC as part of the same episode, or tAP resulting in death during that hospital episode. Critical care was defined as either or both Level 2 or Level 3 inpatient care, also known as high-dependency (HDU) and intensive treatment units (ITU) respectively. Aetiology of AP was defined at two levels: 1) in the entire cohort, AP was attributed to gallstones if this (or a related diagnosis, for example cholecystectomy) was recorded in any coding position; the remainder was regarded as non-gallstone AP; 2) aetiology recorded explicitly in hospital or GP records as gallstones, alcohol or other less common causes. A GP visit was defined as a patientpractice interaction recorded as a visit event in GP records, without being able to differentiate between an actual medical consultation and other, for example obtaining results, visiting the practice nurse or getting a repeat prescription. The day of hospital admission was defined as day zero, and the next day after hospital admission as day 1 and so on. Overall hospital mortality was defined as death during a single episode of AP occurring prior to hospital discharge. Overall 90-day mortality was defined as any death occurring within 90 days of the first day of an episode of AP.
Variables
The primary outcome of interest was the development of sAP (admission to CC, tAP 
Record Linkage
Data were linked using established probability and deterministic matching techniques 17 based on the Howard Newcombe principles 18 
Statistical methods
Descriptive analyses were performed according to standard principles using SAS 9.3 and following the STROBE criteria 20 . Categorical variables were reported as counts and percentages of the number of valid cases. Continuous variables were described by either mean and standard deviation (for plausibly Normal data) or medians and quartiles (non-Normal data). Between group comparisons for univariate analyses were by independent samples t-test or Mann-Whitney U-test for Normal data and nonNormal data respectively. Differences in proportions were tested by the χ 2 test. To correct for extreme outliers in an otherwise Normally distributed dataset, the 5% trimmed mean was used where stated; this value is the arithmetic mean of data between the 5 th and 95 th centile. Time-to-event variables were summarized using medians and quartiles. Factors predicting the development of sAP in the tAP cohort were modeled by logistic regression with sAP as binary dependent variable. Variables were selected on the basis of known clinical importance as well as backward elimination to identify variables significant at the 5% level. The final model was also assessed for goodness-of-fit using Akaike's Information Criterion (AIC). Interactions between variables were entered and assessed by adding interaction terms in the model.
Predictive performance of the model was assessed by estimation of the Area under the ROC curve (AUROC) and calibration assessed with the Hosmer-Lemeshow test. The final model for prediction was based on the largest AUROC. A number of parametric survival models were applied to identify factors that predict death during the CC admission. AIC was used to decide on which model was optimal. Model selection criteria were the same as for the logistic regression model.
Imputation of missing data
For the logistic regression model, where clinically important variables had less than 50% missing values, multiple imputation was used to ensure regression analysis was robust assuming data was missing at random (MAR). In practice, 19% of calcium measures at index admission were imputed along with 35% of the primary care flag for alcohol dependency. All other variables in the models were 100% complete.
Results
Participants and univariate analysis
3340 individuals were identified as having an AP coded hospital admission, of which 2053 (61.5%) met the case definition of tAP and were included in the study. Figure 1 shows patient flow in the study. The incidence of an AP-coded hospital admission was 54.0 (95% CI 41.1, 70.9) per 100 000 per year; the incidence of tAP was 33.1 (95% CI 24.4, 46.9) per 100 000 per year; and the incidence of sAP requiring CC admission was 5.9 (95% CI 3.4, 15.3) per 100 000 per year. Demographic characteristics of the cohort are shown in Table 1 . Gender distribution was approximately equal across all categories and only increased marginally towards a male preponderance for those with sAP admitted to critical care. The mean age of those with sAP was significantly higher than those who did not develop severe disease. Gallstones were co-recorded in 43.8% of the entire cohort coded as AP. The proportion of patients with gallstone aetiology AP was higher for females. The BMI of patients admitted to CC was on average 1.1 kg/m 2 higher than the remainder of the tAP cohort. A disproportionate number of tAP admissions (35.3%) were from the most socially deprived quintile; this disproportion was similarly observed in the subset with sAP (35.0%). The proportion of patients with tAP who develop sAP and the proportion of those requiring CC admission were not affected by social deprivation ( Table 1) . 
Healthcare in General Practice prior to study episode of AP
The GP consultation rate in the year preceding the index AP episode was higher in the subset of patients that died without being admitted to CC than those patients requiring CC or those that did not develop severe AP ( Table 2 ). 25.6% of patients with an episode of tAP had a previous episode of AP recorded in their GP-held record, but a smaller proportion (18.5%) of those with sAP had a previous AP episode documented. Although the aetiology of AP could be attributed to gallstones in 43% of patients, gallstones were only known to be present (in advance of the index episode) in 17.7% of those with tAP.
A similar proportion (16.5%) had been admitted to hospital following alcohol misuse prior to the index episode. The proportion with a prior episode of alcohol-related hospital admission was not higher in the sAP group.
There was a greater baseline comorbidity burden amongst patients with sAP compared to the remainder of the cohort. Pre-existing ischemic heart disease (previous MI or IHD/angina) was more prevalent in those with sAP needing CC admission than in the tAP cohort as a whole ( Table 2) . Pre-existing type 2 diabetes mellitus was significantly more prevalent in those with sAP requiring CC compared to the tAP cohort.
Similarly, chronic obstructive pulmonary disease, hypertension, and renal failure (acute and chronic) were significantly more prevalent among the sAP cohort requiring CC admission ( Table 2 ).
The following classes of drug were prescribed more frequently in those with sAP compared to the nsAP group: antidepressants, calcium-altering drugs, neuroleptic agents, oral corticosteroids and statins. The proportions of patients taking each class of drug are presented in Table 3 .
Endoscopic retrograde cholangiopancreatography (ERCP) had been undertaken in the preceding year in 5.6% of those admitted with tAP. This proportion was not higher in those with sAP. Coronary artery stenting had been performed in the preceding year more frequently in those with sAP requiring CC (3.0%) compared to the nsAP cohort (1.0%) ( Table 3) . calendar days of CC care ( Table 5 ).
The median (IQR) APACHE-2 score on admission to CC was 19 (14, 24) . The number of organ systems requiring support is presented in Table 4 . A small proportion of sAP patients (24/368 (6.5%)), were admitted for close observation without any recorded organ support. During the initial admission, cardiovascular support with vasopressors was used in 60.3% of sAP patients, but this value rose to 65.5% when all CC admissions were considered. 13.9% required mechanical ventilation on the first admission, rising to 18.1% when all CC admissions for that AP episode were considered.
4.8% required invasive renal replacement therapy at any point during CC admission. 
Factors predicting sAP (admission to critical care or death)
The results of the logistic model predicting sAP in those with tAP are given in 
Mortality
Overall in-hospital mortality was defined for tAP patients only and was 102/2053 (5.0%). Overall 90-day mortality for the tAP cohort was 127/2053 (6.2%) and for the sAP cohort was 100/390 (25.6%). In-hospital mortality amongst sAP admitted to critical care was 80/368 (21.7%), of whom 54/368 (14.7%) died in CC and 26/368 (7.1%) died in hospital after discharge from CC ( Table 5) .
Patients who died in CC died after a median (1 st , 3 rd quartile) of 70 (25, 371) hours after CC admission ( Table 5 ). The median time from hospital admission to death for those dying in CC was 82 (26,371) hours, from which it can be inferred that the median time between admission to hospital and admission to CC was 12 hours ( Table  5) . Patients who died in hospital after discharge from CC died after a median (1 st , 3 rd quartile) of 9.9 (5.1, 21.9) days and mean 23.0 days after CC admission. were admitted from private residence rather than a nursing home and 2/22 lived alone.
Because pre-hospital and early mortality in severe AP is greater in rural areas 21 , we examined postcodes for this patient subgroup. 20/22 were from urban postcodes. The mean ± SD age of these 22 patients was 74 ± 14 years and median (range) 72 (46 to 92) years. The median BMI (1 st , 3 rd quartile) for these 22 patients was significantly lower (22. 1 (18.9, 30.7) ) than the respective measures for the remainder of the tAP cohort.
Risk of death after critical care admission
The results of fitting the parametric Gamma model (lowest AIC) are shown in Table 7 and Figure 2 . Generally negative regression coefficients indicate factors that shorten the time to death. The only factor that was positive was T2 DM, which gave a time ratio 
Discussion
Acute pancreatitis is associated with a high mortality, shortens overall life expectancy in survivors 22 and constitutes a considerable healthcare resource burden 7-9 13 . Specifically, the evolution of persistent organ dysfunction requiring critical care (CC) support has the most deleterious short and long term consequences in AP. Building on previous work by others 23 24 , in this cross-sectional observational study, we have brought together sixteen electronic healthcare records into a single national Safe Haven overseen by the Farr Institute governance structure to conduct a detailed study of the development of organ dysfunction and CC admission in AP.
These data confirm a disproportionately high incidence of AP in the most multiply deprived quintiles of areas, in keeping with previous observations by us and others 25 , and that CC admission during an episode of AP has a high (21.7%) mortality has not been ascertained from our data, despite our efforts to do so; it is possible that this observation may reflect differences in older persons, or reflect a confounder in our dataset that we have been unable to uncover. Once admitted to CC, factors predictive of death included cardiovascular stenting and thyroid or parathyroid surgery within the previous year.
The overall mortality seen in our study is comparable with that seen in other large epidemiological studies in the UK 26 , the US 7 8 , Taiwan 2 , Japan 4 and South Africa 27 .
The mortality in the population of patients with tAP requiring CC in the present cohort is somewhat higher than many other reported studies, and certainly the APACHE-II score on admission to CC was higher than the average for the general ICU population in the Scottish system 28 . Patients admitted to CC who subsequently died were admitted to CC sooner (median 12 hours, mean 14 hours) after hospital admission than the overall 5% trimmed mean for overall sAP-CC cohort of 1.83 days ( Table 4) . Therefore, nonsurvivors were admitted to CC sooner after hospital admission than eventual survivors.
It is likely that this is a consequence of more severe AP in non-survivors triggering earlier CC admission criteria. A second alternative explanation is that it is possible that a faster evolution variant of AP is more lethal, or that this subgroup of patients is more susceptible to rapid evolution of disease. Lastly, this observation may reflect a delay in presentation to hospital leading to increased mortality in those not presenting promptly for treatment.
Independent predictors of severe disease in tAP included a history of angina and hypertension. It is logical that patients with pre-existing chronic heart disease would be at increased risk of death once they develop organ dysfunction, and this is borne out in our study by the association between coronary stenting in the preceding year and risk of death after CC admission. However, it is not as straightforward to link angina and hypertension with an increased likelihood of needing CC admission in the context of an AP episode. Angina and hypertension in this scenario may be confounders, acting as surrogate markers of other chronic health conditions that directly reduce the threshold for developing organ dysfunction requiring CC, or they may indicate a lack of physiological compensatory reserve in critical illness, such that for a given inflammatory insult there is greater physiological derangement.
Our observation that a higher number of previous admissions with AP reduces the risk for CC admission or death during a subsequent AP episode is novel. It is uncertain whether this is a result of increased individual likelihood of developing systemic organ dysfunction with particular severity of inflammatory insult, or whether frequent A&E attenders, particularly with regard to alcohol overuse represent a different subset of patients.
The relationship between fluctuations in serum calcium and pancreatitis is known 29 and the association between thyroid and parathyroid surgery and death after CC admission, and between hypocalcemia and calcium-altering drugs is not surprising.
Hypo-or hypercalcemia is recognized in both the Imrie 30 and Ranson 31 scoring systems, and there is a wealth of preclinical experimental evidence of deranged calcium signaling as a mechanism of pancreatic acinar cell injury 32 .
Strengths of study
The main strength of this study is the coalition of multiple electronic data sources linked though a unique identifier on a national basis. Critical to this process was strict data protection. This was achieved through the use of a centralized protected safe haven and minimizing the number of individuals with access to the non-anonymised primary data. Furthermore, industry partners could be fully involved in the protocol design and processes surrounding the data collection and depository without needing sight of any primary data. Combining detailed inpatient CC information collected at high temporal resolution and integrating this with broad background data derived from community data sources was achieved.
Limitations and Bias
Limitations of this study include an inability to gain information in electronic form on routinely recorded clinical data from those inpatients that did not require CC. This may have led to negative reporting bias for events that might be relevant to this study but not sufficiently severe to necessitate CC admission. In addition, we are unable to ascertain exactly how many individuals might have met criteria for CC admission but not admitted due to advance directives or limited capacity. A further limitation inherent to the study design based on routinely collected data is the relative lack of confirmation of the accuracy of source data entry. Although we specifically conducted a coding accuracy pilot for the diagnosis of AP, comparing electronic records with hand-written notes in four separate study sites, and while certain variables are likely to be highly accurate, for example automatically-retrieved Wardwatcher™ critical care data, laboratory values and date of death on death certificates, certain other fields are impossible to ratify accurately. We include in the latter category comorbidity and clinical information recorded in hospital discharge summaries.
Conclusions
National record-linkage analyses from a wide variety of routinely collected primary and secondary care data sources are feasible and constitute a powerful resource. Factors that predict sAP are distinct from those that prognosticate mortality. Mortality in patients with AP who require CC admission remains high. 
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